| Structure |
Chemical Name |
CAS |
MF |
 |
Tiprolisant oxalate |
362665-57-4 |
C19H28ClNO5 |
 |
XL 228 |
898280-07-4 |
C22H31N9O |
 |
SAR-407899 |
923262-96-8 |
C14H17ClN2O2 |
 |
NS-6180 |
353262-04-1 |
C16H12F3NOS |
 |
GSK2110183B |
1047645-82-8 |
C18H18Cl3FN4OS |
 |
GNE 617 |
1362154-70-8 |
C21H15F2N3O3S |
 |
NSC 55712 |
2076-91-7 |
C8H14Cl2N4S3 |
 |
Pasireotide |
396091-73-9 |
C58H66N10O9 |
 |
GSK J2 |
1394854-52-4 |
C22H23N5O2 |
 |
5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride |
1234015-54-3 |
C18H21Cl2N7O2 |
 |
AVE0991 |
304462-19-9 |
C29H32N4O5S2 |
 |
Antibiotic A 40926 |
102961-72-8 |
C83H86Cl2N8O30 |
 |
Posaconazole (hydrate) |
1198769-38-8 |
C37H44F2N8O5 |
 |
GSK-3 inhibitor 1 |
603272-51-1 |
C22H17ClFN5O2 |
 |
Mutant IDH1 inhibitor |
1429180-08-4 |
C25H34N6O3 |
 |
SDZ 220-581 (hydrochloride) |
179411-93-9 |
C16H18Cl2NO5P |
 |
PTC-209 (PTC209 |
315704-66-6 |
C17H13Br2N5OS |
 |
Tenovin 6 (Hydrochloride) |
1011301-29-3 |
C25H35ClN4O2S |
 |
(R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol |
1235481-43-2 |
C22H20Br2N2O2 |
![4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide](/CAS/GIF/312756-74-4.gif) |
4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide |
312756-74-4 |
C20H16Br2N2O3S |
 |
AMG 232 |
1352066-68-2 |
C28H35Cl2NO5S |
 |
AZD1283 |
919351-41-0 |
C23H26N4O5S |
 |
ETP-46321 |
1252594-99-2 |
C20H27N9O3S |
 |
Tenofovir alafenamide fumarate |
379270-38-9 |
C25H33N6O9P |
 |
LY2857785 |
1619903-54-6 |
C26H36N6O |
 |
ML216 |
1430213-30-1 |
C15H9F4N5OS |
 |
THZ1 |
1604810-83-4 |
C31H28ClN7O2 |
 |
ABT-267 |
1258226-87-7 |
C50H67N7O8 |
 |
INK1117 |
1268454-23-4 |
C19H17N5O3 |
 |
ISRIB |
548470-11-7 |
C22H24Cl2N2O4 |
![(S)-3-(aMinoMethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3H)-ol](/CAS/20150408/GIF/1234563-16-6.gif) |
(S)-3-(aMinoMethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3H)-ol |
1234563-16-6 |
C11H16BNO4 |
 |
K-Ras G12C-IN-1 |
1629265-17-3 |
C22H23Cl2N3O3 |
 |
MAChR-IN-1 |
119391-56-9 |
C23H25IN2O2 |
 |
FMoc-Val-Cit-PAB |
159858-22-7 |
C33H39N5O6 |
![K-7174, 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine](/CAS/GIF/191089-60-8.gif) |
K-7174, 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine |
191089-60-8 |
C33H48N2O6 |
 |
Neurodye DiBAC4(5) |
63560-89-4 |
C29H42N4O6 |
 |
N'α-Histidylhistidin |
306-14-9 |
C12H16N6O3 |
 |
CY3 NHS ESTER |
146368-16-3 |
C35H41N3O10S2 |
 |
H-D-Ser(OBzl)-OH HCl |
1233494-98-8 |
C10H14ClNO3 |
 |
FMOC-ASPARTIMOL(OTBU) |
133565-45-4 |
C23H27NO5 |
 |
FMOC-DAB(DDE)-OH |
|
C30H34N2O5 |
 |
BIOCYTIN HYDRAZIDE HYDROCHLORIDE |
102743-85-1 |
C16H30N6O3S |
 |
N-BOC-3-AMINO-4-CHLOROBENZOIC ACID |
160450-12-4 |
C12H14ClNO4 |
 |
N2-tryptophyllysine |
51790-14-8 |
C17H24N4O3 |
 |
BOC-L-MEPHE(4-CL)-OH |
179033-68-2 |
C15H20ClNO4 |
 |
Ac-D-Glu(OtBu)-OH |
|
C11H19NO5 |
|
|
Fmoc-D-Glu-OH |
|
C20H19NO6 |
|
|
Fmoc-Ser-OPAC |
|
C26H23NO6 |
 |
FMOC-5-AMINOPENTANOIC ACID |
123622-48-0 |
C20H21NO4 |
 |
FMOC-HIS(MMT)-OH |
133367-33-6 |
C41H35N3O5 |
 |
6-CARBOXYTETRAMETHYLRHODAMINE N-HYDROXYSUCCINIMIDE ESTER |
150810-68-7 |
C29H25N3O7 |
 |
FMOC-L-INDOLINE-2-CARBOXYLIC ACID |
198560-38-2 |
C24H19NO4 |
 |
5-Methyl-1,3-dihydroisobenzofuran-1-one |
54120-64-8 |
C9H8O2 |
 |
para-Lacto-N-octaose |
150517-85-4 |
C54H91N3O41 |
 |
DBPR108 |
1186426-66-3 |
C16H25FN4O2 |
 |
OTS964 hydrochloride |
1338545-07-5 |
C23H24N2O2S |
![7-nitro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione](/CAS/20180629/GIF/73043-80-8.gif) |
7-nitro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione |
73043-80-8 |
C9H6N2O5 |
 |
TH588 |
1609960-31-7 |
C13H12Cl2N4 |
 |
SEP-0372814 |
1516895-53-6 |
C21H19N7 |
 |
RI-2 |
1417162-36-7 |
C21H18Cl2N2O4 |
 |
3-(4-TERT-BUTOXYCARBONYLAMINO-PHENYL)-PROPIONIC ACID |
149506-05-8 |
C14H19NO4 |
 |
BOC-(R)-3-AMINO-4-(3-PYRIDYL)-BUTYRIC ACID |
269396-65-8 |
C14H20N2O4 |
 |
CHRYSAMINE G |
6472-91-9 |
C26H16N4O6.2Na |
 |
BOC-SER(FMOC-GLY)-OH |
944283-06-1 |
C25H28N2O8 |
 |
3-TERT-BUTOXYCARBONYLAMINO-3-THIOPHEN-2-YL-PROPIONIC ACID |
53030-49-2 |
C12H17NO4S |
 |
Fmoc-7-bromo-DL-tryptophan |
1219370-30-5 |
C26H21BrN2O4 |
 |
Fmoc-5-chloro-DL-tryptophan |
1219398-51-2 |
C26H21ClN2O4 |
 |
Fmoc-NH-PEG8-CH2CH2COOH |
756526-02-0 |
C34H49NO12 |
 |
5-Carboxyrhodamine 6G succinimidyl ester |
209112-21-0 |
C31H29N3O7 |
 |
BOC-TYR(ET)-OH |
247088-44-4 |
C16H23NO5 |
 |
BOC-DL-3-AMINOBUTYRIC ACID |
52815-19-7 |
C9H17NO4 |
 |
FMOC-(S)-2-AMINO-3-HYDROXY-3-METHYLBUTANOIC ACID |
1217603-41-2 |
C20H21NO5 |
 |
HOE-32020 |
23554-99-6 |
C25H23ClN6 |
 |
Hoechst 33258 analog 3 |
23554-98-5 |
C26H26N6 |
|
|
Cy3 azide |
2183440-48-2 |
|
 |
4-((4-(DIMETHYLAMINO)PHENYL)AZO)BENZOIC ACID, SUCCINIMIDYL ESTER |
146998-31-4 |
C19H18N4O4 |
 |
BOC-(S)-3-AMINO-4-(3-PYRIDYL)-BUTYRIC ACID |
208404-16-4 |
C14H20N2O4 |
 |
BOC-CIT-OH |
45234-13-7 |
C11H21N3O5 |
 |
BOC-PHE-MERRIFIELD RESIN |
|
C14H18NO3R |
 |
H-ASP(LEU-OH)-OH |
14650-26-1 |
C10H18N2O5 |
 |
H-N-Me-D-Leu-OBzl·TosOH |
1208162-98-4 |
C21H29NO5S |
 |
(2R,4S)-N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-4-HYDROXYPYRROLIDINE-2-CARBOXYLIC ACID |
139262-20-7 |
C20H19NO5 |
|
|
BEYOPURE TRYPTONE/BEYOPURE Tryptone |
|
|
|
|
Phosphate buffer (pH7.8) |
|
|
|
|
Bromocresol green indicator solution |
|
|
 |
2-Buten-1-amine, 3,4,4-trifluoro-4-(phenylsulfonyl)-, hydrochloride (1:1), (2Z)- |
2584947-79-3 |
C10H10F3NO2S.ClH |
 |
(-)-5-Caffeoyl quinic acid |
202650-88-2 |
C16H18O9 |
 |
3-(TrifluoroMethyl)Azetidine Hydrochloride |
1221272-90-7 |
C4H7ClF3N |
 |
(S)-2-((S)-2-(tert-butoxycarbonylaMino)-3-MethylbutanaMido)propanoic acid |
70396-18-8 |
C13H24N2O5 |
 |
N-(Allyloxy)-2-nitrobenzenesulfonaMide |
359442-67-4 |
C9H10N2O5S |
![[1,2,4]Triazolo[1,5-a]pyrazin-2-amine](/CAS/20180703/GIF/88002-33-9.gif) |
[1,2,4]Triazolo[1,5-a]pyrazin-2-amine |
88002-33-9 |
C5H5N5 |
 |
(R)-4-Aminopyrrolidin-2-one hydrochloride |
1788058-41-2 |
C4H9ClN2O |
 |
4-chloro-2-(6-methoxypyrimidin-4-yl)aniline |
1802434-18-9 |
C11H10ClN3O |
 |
(6R,9R,12R)-6,9-dibenzyl-12-isobutyl-2,2-dimethyl-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oic acid |
1024829-72-8 |
C29H39N3O6 |
![ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate(WXG02032)](/CAS/20180703/GIF/1206124-13-1.gif) |
ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate(WXG02032) |
1206124-13-1 |
C15H17NO3 |
 |
5-AMINO-6-HYDROXYPYRIDINE-3-CARBOXYLIC ACID |
1367986-63-7 |
C6H6N2O3 |
 |
3-(3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid HCL |
2242751-53-5 |
C15H18ClFN2O3 |
 |
(2-Carboxylatophenyl)phenyliodonium |
1488-42-2 |
C13H9IO2 |
|
|
2-Chloro-4-fluoroaniline |
|
|
![1-(4-Aminobutyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine](/CAS/20200611/GIF/313350-31-1.gif) |
1-(4-Aminobutyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine |
313350-31-1 |
C18H25N5 |